Antiangiogenic therapy for patients with recurrent and newly diagnosed malignant gliomas.

J Oncol · 2012 · PMC3139866 · PMID 21804824

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients treated with 2000 mg showed a trend toward better results with 6-month PFS of 15%.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.